Evelo Biosciences Inc
EVLO
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.9K
Close$
Share Statistics
| Market cap | $1,898.00 |
|---|---|
| Enterprise Value | $24.19 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-26.28 |
| Beta | 1.67 |
| Outstanding Shares | 173,842 |
Return
| Return on Equity | 308.34% |
|---|---|
| Return on Assets | -399.23% |
| Return on Invested Capital | 393.16% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.32 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.71 |
| Debt to Equity | -1.55 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-10.40
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 10, 2026
EPS Estimate
$-10.40
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data